Statins and diabetes mellitus: price of collaboration
It is now well established that clinical use of statins for primary and secondary prevention of cardiovascular complications in patientswith diabetes mellitus (DM) increases life expectancy. At the same time, meta-analysis of major randomized trials shows statins to increaseglycemic levels and incid...
Enregistré dans:
Auteurs principaux: | Andrey Alexeevich Aleksandrov, Maria Nikolaevna Yadrikhinskaya, Svetlana Semenovna Kukharenko, Olga Alexandrovna Shatskaya |
---|---|
Format: | article |
Langue: | EN RU |
Publié: |
Endocrinology Research Centre
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d1621016038b4a5abe471d23edeb8a2c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Cardiovascular implications of modern algorithm of hypoglycemic therapy: ?Florentine hypothesis?
par: Andrey Alexeevich Aleksandrov, et autres
Publié: (2010) -
Atrial fibrillation: a new facet of diabetes mellitus in the XXI century
par: Andrey Alexeevich Aleksandrov, et autres
Publié: (2011) -
Statin use and risk of diabetes mellitus
par: Oksana Mikhailovna Drapkina, et autres
Publié: (2012) -
ACE inhibitors as a risk factor for hypoglycemia
par: Andrey Alexeevich Aleksandrov, et autres
Publié: (2011) -
Prescribing frequency and adherence to statins in outpatients with type 2 diabetes mellitus and comorbid cardiovascular diseases
par: Victoriya N. Serebryakova, et autres
Publié: (2021)